Kelly Moreland East

Ms. Kelly Moreland East


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2017 in Genome Medicine
Verified
Journal Article
Open access
PDF file
KBKevin M. Bowling
Kevin M. Bowling
MTMichelle Thompson
Michelle Thompson
MAMichelle D. Amaral
Michelle D. Amaral
CFCandice R. Finnila
Candice R. Finnila
SHSusan M. Hiatt
Susan M. Hiatt
GCGregory M. Cooper
Gregory M. Cooper
Developmental disabilities have diverse genetic causes that must be identified to facilitate precise diagnoses. We describe genomic data from 371 affected individuals, 309 of which were sequenced as proband-parent trios. Whole-exome sequences (WES) were generated for 365 individuals (127 affected) and whole-genome sequences (WGS) were generated for 612 individuals (244 affected). Pathogenic or likely pathogenic variants were found in 100 individuals (27%), with variants of uncertain significance in an additional 42 (11.3%). We found that a family history of neurological disease, especially the presence of an affected first-degree relative, reduces the pathogenic/likely pathogenic variant identification rate, reflecting both the disease relevance and ease of interpretation of de novo variants. We also found that improvements to genetic knowledge facilitated interpretation changes in many cases. Through systematic reanalyses, we have thus far reclassified 15 variants, with 11.3% of families who initially were found to harbor a VUS and 4.7% of families with a negative result eventually found to harbor a pathogenic or likely pathogenic variant. To further such progress, the data described here are being shared through ClinVar, GeneMatcher, and dbGaP. Our data strongly support the value of large-scale sequencing, especially WGS within proband-parent trios, as both an effective first-choice diagnostic tool and means to advance clinical and research progress related to pediatric neurological disease.

27 November 2020 in Genetics in Medicine
Verified
Journal Article
Closed access
KEKelly Moreland East
Kelly Moreland East
WKWhitley V. Kelley
Whitley V. Kelley
ACAshley Cannon
Ashley Cannon
MCMeagan E. Cochran
Meagan E. Cochran
IMIrene P. Moss
Irene P. Moss
BKBruce R. Korf
Bruce R. Korf

5 June 2015 in Personalized Medicine
Verified
Journal Article
Open access
LALaura Amendola
Laura Amendola
DLDenise Lautenbach
Denise Lautenbach
SSSarah Scollon
Sarah Scollon
BBBarbara Bernhardt
Barbara Bernhardt
SBSawona Biswas
Sawona Biswas
GJGail P Jarvik
Gail P Jarvik
Whole genome and exome sequencing tests are increasingly being ordered in clinical practice, creating a need for research exploring the return of results from these tests. A goal of the Clinical Sequencing and Exploratory Research (CSER) consortium is to gain experience with this process to develop best practice recommendations for offering exome and genome testing and returning results. Genetic counselors in the CSER consortium have an integral role in the return of results from these genomic sequencing tests and have gained valuable insight. We present seven emerging themes related to return of exome and genome sequencing results accompanied by case descriptions illustrating important lessons learned, counseling challenges specific to these tests and considerations for future research and practice.

Verified
Journal Article
Open access
PDF file
KEKelly Moreland East
Kelly Moreland East
MCMeagan E. Cochran
Meagan E. Cochran
WKWhitley V. Kelley
Whitley V. Kelley
VGVeronica Greve
Veronica Greve
CFCandice R. Finnila
Candice R. Finnila
GCGreg Cooper
Greg Cooper
To meet current and expected future demand for genome sequencing in the neonatal intensive care unit (NICU), adjustments to traditional service delivery models are necessary. Effective programs for the training of non-genetics providers (NGPs) may address the known barriers to providing genetic services including limited genetics knowledge and lack of confidence. The SouthSeq project aims to use genome sequencing to make genomic diagnoses in the neonatal period and evaluate a scalable approach to delivering genome sequencing results to populations with limited access to genetics professionals. Thirty-three SouthSeq NGPs participated in a live, interactive training intervention and completed surveys before and after participation. Here, we describe the protocol for the provider training intervention utilized in the SouthSeq study and the associated impact on NGP knowledge and confidence in reviewing, interpreting, and using genome sequencing results. Participation in the live training intervention led to an increased level of confidence in critical skills needed for real-world implementation of genome sequencing. Providers reported a significant increase in confidence level in their ability to review, understand, and use genome sequencing result reports to guide patient care. Reported barriers to implementation of genome sequencing in a NICU setting included test cost, lack of insurance coverage, and turn around time. As implementation of genome sequencing in this setting progresses, effective education of NGPs is critical to provide access to high-quality and timely genomic medicine care.

Verified
Journal Article
Open access
PDF file
ALAmy A. Lemke
Amy A. Lemke
MTMichelle Thompson
Michelle Thompson
EGEmily C. Gimpel
Emily C. Gimpel
KMKatelyn C. McNamara
Katelyn C. McNamara
CRCarla A. Rich
Carla A. Rich
KBKyle B. Brothers
Kyle B. Brothers
Background: It is critical to understand the wide-ranging clinical and non-clinical effects of genome sequencing (GS) for parents in the NICU context. We assessed parents’ experiences with GS as a first-line diagnostic tool for infants with suspected genetic conditions in the NICU. Methods: Parents of newborns (N = 62) suspected of having a genetic condition were recruited across five hospitals in the southeast United States as part of the SouthSeq study. Semi-structured interviews (N = 78) were conducted after parents received their child’s sequencing result (positive, negative, or variants of unknown significance). Thematic analysis was performed on all interviews. Results: Key themes included that (1) GS in infancy is important for reproductive decision making, preparing for the child’s future care, ending the diagnostic odyssey, and sharing results with care providers; (2) the timing of disclosure was acceptable for most parents, although many reported the NICU environment was overwhelming; and (3) parents deny that receiving GS results during infancy exacerbated parent–infant bonding, and reported variable impact on their feelings of guilt. Conclusion: Parents reported that GS during the neonatal period was useful because it provided a “backbone” for their child’s care. Parents did not consistently endorse negative impacts like interference with parent–infant bonding.

9 April 2019 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
PDF file
KEKelly Moreland East
Kelly Moreland East
MCMeagan Cochran
Meagan Cochran
WKWhitley V. Kelley
Whitley V. Kelley
VGVeronica Greve
Veronica Greve
KEKristina Emmerson
Kristina Emmerson
DBDavid Bick
David Bick